Latest Form 4 insider transactions

NYSE
Annette Franqui, a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.
NYSE
Andrew Dudum, Chief Executive Officer, a Director and 10% owner of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Lorraine Mitchelmore, a Director of Cheniere Energy, Inc., reported a transaction in 51 shares of common stock on August 15, 2026.
NYSE
Michael Chi, Chief Operating Officer of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 64,771 shares of common stock on June 18, 2026.
NYSE
Deborah M. Autor, Chief Policy Officer and a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
David M Rothenstein, SVP and Chief Strategy Officer of Ciena Corp, sold 2,500 shares of common stock on August 14, 2026 for $438.10 per share.
NYSE
David B Wells, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Irene Becklund, PAO of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Brian D. Goodrich, EVP - General Counsel of First Financial Bankshares Inc, reported multiple transactions in common stock on August 14, 2026.
NYSE
Ann M Kappler, EVP and General Counsel of Prudential Financial Inc, sold 7,652 shares of common stock on August 14, 2026 for $125.01 per share.
NASDAQ
Santos Cardoso Joao Kleber Dos, CFO and Corporate Secretary of Aura Minerals Inc., sold 2,066 shares of common stock on August 17, 2026 for $80.00 per share.
NYSE
Christopher D Payne, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Rodriguez Felix Matos V., a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.
NYSE
Sherri Baker, SVP, CFO of Clearwater Paper Corp, reported a transaction in 4,634 shares of common stock on August 15, 2026.
NYSE
Loren M Starr, a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.
NYSE
Donna Dorsey, Chief Human Resources Officer of Alight, Inc. / Delaware, reported a transaction in 3,833 shares of common stock on August 15, 2026.
NYSE
Dale Burks, Chief Commercial Officer & EVP of Standard Motor Products, Inc., sold 12,551 shares of common stock on August 14, 2026.
NYSE
John Nixon, a Director of Virtu Financial, Inc., sold 9,094 shares of common stock on August 17, 2026 for $60.13 per share.
NYSE
Tracy P. Palandjian, a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.
NYSE
Michael P. Garthwaite, VP (Pres., Products Pipelines) of Kinder Morgan, Inc., sold 1,550 shares of common stock on August 17, 2026 for $32.65 per share.
NYSE
Eric J Aumen, Chief Accounting Officer of Under Armour, Inc., reported a transaction in 3,568 shares of common stock on August 15, 2026.
NYSE
Alissa Michelle Starzak, Chief Legal Officer of Cloudflare, Inc., reported a transaction in 3,775 shares of common stock on August 15, 2026.
NASDAQ
Lindsay J. Radkoski, CMO, U.S. of Wendy's Co, reported multiple transactions in common stock on August 15, 2026.
NASDAQ
Laura Francis, Chief Executive Officer and a Director of SI-BONE, Inc., sold 14,956 shares of common stock on August 17, 2026.
NYSE
Thomas J Seifert, Chief Financial Officer of Cloudflare, Inc., reported a transaction in 2,944 shares of common stock on August 15, 2026.
NYSE
Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc., sold 32,710 shares of common stock on August 14, 2026 for $250.00 per share.
NASDAQ
David Zawitz, Chief Operating Officer of Verrica Pharmaceuticals Inc., purchased 6,000 shares of common stock on August 17, 2026 for $4.98 per share.
NASDAQ
Noah L. Rosenberg, CMO of Verrica Pharmaceuticals Inc., purchased 6,230 shares of common stock on August 17, 2026.